26Feb 2018

ESTIMATION OF SERUM GLYCODELIN A, INSULIN-LIKE GROWTH FACTOR-1 AND INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-3 AT 4TH WEEK GESTATIONAL AGE AS PREDICTORS FOR EARLY PREGNANCY LOSS IN PREGNANT WOMEN WITH POLYCYSTIC OVARY SYNDROME.

  • Department of Obstetrics & Gynecology, Faculty of Medicine, Benha University.
  • Fellow & Researcher of Medical Biochemistry, Hospital Lab., Clinical Pathology department, Faculty of Medicine, Benha University.
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Objectives: To evaluate predictability of estimation of serum levels of glycodelin A (GdA), insulin growth factor-1 (IGF-1) and its binding protein-3 (IGFBP-3) at the 4th week gestation age (GA) for development of early pregnancy loss (EPL) in primigravida with polycystic ovary syndrome (PCOS). Patients & Methods: The study included 45 primigravida PCOS women developed EPL (Study group) and 45 primigravida PCOS women completed the observation period uneventfully (Control group). At the 4th wk GA, all women underwent clinical examination and pregnancy was assured, then all women gave fasting blood samples for estimation of fasting blood glucose (FBG), serum insulin, GdA, IGF-1 and IGFBP-3. Insulin resistance (IR) was evaluated using the homeostasis model assessment IR (HOMA-IR) score. Results: Study women had significantly higher FBG and HOMA-IR score than control women. Estimated 4-wk GA serum levels of IGF-1 were significantly higher, while serum IGFBP-3 and GdA were significantly lower in study versus control PCOS women. Development of EPL showed positive significant correlation with high FBG, HOMA-IR score and high serum IGF-1 levels, while showed negative significant correlation with serum IGFBP-3 and GdA levels. Statistical analyses defined high serum IGF-1 as significant sensitive predictor, while low serum glycodelin A, IGFBP-1 and FBG as specific predictors for development of EPL, in decreasing order of significance. Conclusion: Low serum GdA and IGFBP-3 levels and high IGF-1 levels estimated at the 4th wk GA may underlie the development of EPL in pregnant PCOS women. Estimation of three markers as multiple marker panels could predict EPL with high sensitivity and specificity.


1. McDonnell R, Hart RJ: Pregnancy-related outcomes for women with polycystic ovary syndrome. Womens Health (Lond). 2017; 13(3):89-97. 2. Kamalanathan S, Sahoo JP, Sathyapalan T: Pregnancy in polycystic ovary syndrome. Indian J Endocrinol Metab. 2013; 17(1):37-43. 3. Piltonen TT: Polycystic ovary syndrome: Endometrial markers. Best Pract Res Clin Obstet Gynaecol. 2016; 37:66-79. 4. Desai NA, Patel SS: Increased insulin-like growth factor-1 in relation to cardiovascular function in polycystic ovary syndrome: friend or foe? Gynecol Endocrinol. 2015; 31(10):801-7. 5. Chen L, Xu WM, Zhang D: Association of abdominal obesity, insulin resistance, and oxidative stress in adipose tissue in women with polycystic ovary syndrome. Fertil Steril. 2014; 102(4):1167-1174. 6. Baillargeon JP, Iuorno MJ, Apridonidze T, Nestler JE: Uncoupling between insulin and release of a D-chiro-inositol-containing inositolphosphoglycan mediator of insulin action in obese women with polycystic ovary syndrome. Metab Syndr Relat Disord. 2010; 8(2):127-36. 7. Street ME, Spaggiari C, Volta C, Ziveri MA, Viani I, Rossi M, Pisi G, Grzincich G, Bernasconi S: The IGF system and cytokine interactions and relationships with longitudinal growth in prepubertal patients with cystic fibrosis. Clin Endocrinol (Oxf). 2009; 70(4):593-8. 8. Sohma Y, Hua QX, Liu M, Phillips NB, Hu SQ, Whittaker J, Whittaker LJ, Ng A, Roberts CT Jr, Arvan P, Kent SB, Weiss MA: Contribution of residue B5 to the folding and function of insulin and IGF-I: constraints and fine-tuning in the evolution of a protein family. J Biol Chem. 2010; 285(7):5040-55. 9. Lee H, Oh JY, Sung YA: Adipokines, insulin-like growth factor binding protein-3 levels, and insulin sensitivity in women with polycystic ovary syndrome. Korean J Intern Med. 2013; 28(4):456-63. 10. Schiefner A, Rodewald F, Neumaier I, Skerra A: The dimeric crystal structure of the human fertility lipocalin glycodelin reveals a protein scaffold for the presentation of complex glycans. Biochem J. 2015; 466(1):95-104. 11. So KH, Lee CL, Yeung WS, Lee KF: Glycodelin suppresses endometrial cell migration and invasion but stimulates spheroid attachment. Reprod Biomed Online. 2012; 24(6):639-45. 12. Khosla T, Lowe CR: Indices of obesity derived from body weight and height. Br J Prev Soc Med., 1967; 21: 121-8. 13. WHO expert consultation. Appropriate Body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet, 2004; 157-63. 14. Matthews DR, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 1985; 28:412?9. 15. Ascaso JF, Romero P, Real JT, Priego A, Valdecabres C, Carmena R: Insulin resistance quantification by fasting insulin plasma values and HOMA index in a non-diabetic population. Med Clin (Barc), 2001; 117: 530?3. 16. Tinder P: Determination of blood glucose. Ann. Clin. Biochem.; 6:24, 1969. 17. Gordon C, Yates AP, Davies D: Evidence for a direct action of exogenous insulin on the pancreatic islets of diabetic mice: islet response to insulin pre-incubation. Diabetologia, 1985; 28, 291?4. 18. Lamson G, Giudice I, Rosenfeld R: Insulin-like growth factor binding proteins:structural and molecular relationships. Growth factors, 1991; 5: 19. 19. Underwood LE, Murphy MG: Radioimmunoassay of the somatomedins (IGF-1, IGF-2). In: Radioimmunoassay in Basic and Clinical Pharmacology, Patrano C (ed.), Springer-Verlag, Heldberg.; Pp: 561, 1987. 20. Rausch M, Sammel S, Takacs E: Development of a multiple marker test for ectopic pregnancy. Obstetrics and gynecology, 2011; 117: 573-82, 2011. 21. Nawaz FH, Rizvi J: Continuation of metformin reduces early pregnancy loss in obese Pakistani women with polycystic ovarian syndrome. Gynecol Obstet Invest. 2010; 69:184-9. 22. Al-Biate MA: Effect of metformin on early pregnancy loss in women with polycystic ovary syndrome. Taiwan J Obstet Gynecol. 2015; 54(3):266-9. 23. Banu J, Fatima P, Sultana P, Chowdhury MA, Begum N, Anwary SA, Ishrat S, Deeba F, Begum SA: Association of infertile patients having polycystic ovarian syndrome with recurrent miscarriage. Mymensingh Med J. 2014; 23(4):770-3. 24. Joham AE, Boyle JA, Ranasinha S, Zoungas S, Teede HJ: Contraception use and pregnancy outcomes in women with polycystic ovary syndrome: data from the Australian Longitudinal Study on Women's Health. Hum Reprod. 2014; 29(4):802-8. 25. Wang Y, Zhao H, Li Y, Zhang J, Tan J, Liu Y: Relationship between recurrent miscarriage and insulin resistance. Gynecol Obstet Invest. 2011; 72(4):245-51. 26. Cho LW, Kilpatrick ES, Keevil BG, Jayagopal V, Coady AM, Rigby AS, Atkin SL: Insulin resistance variability in women with anovulatory and ovulatory polycystic ovary syndrome, and normal controls. Horm Metab Res. 2011; 43(2):141-5. 27. Celik N, Evsen MS, Sak ME, Soydinc E, Gul T: Evaluation of the relationship between insulin resistance and recurrent pregnancy loss. Ginekol Pol. 2011; 82(4):272-5. 28. Maryam K, Bouzari Z, Basirat Z, Kashifard M, Zadeh MZ: The comparison of insulin resistance frequency in patients with recurrent early pregnancy loss to normal individuals. BMC Res Notes. 2012; 5:133. 29. Li ZL, Xiang HF, Cheng LH, Cao YX, Wei ZL, Liu C, Hu JJ, Pan FM: Association between recurrent miscarriages and insulin resistance: a meta analysis. Zhonghua Fu Chan Ke Za Zhi. 2012; 47(12):915-9. 30. Hong Y, Xie QX, Chen CY, Yang C, Li YZ, Chen DM, Xie MQ: Insulin resistance in first-trimester pregnant women with pre-pregnant glucose tolerance and history of recurrent spontaneous abortion. J Biol Regul Homeost Agents. 2013; 27(1):225-31. 31. Kelly CJ, Stenton SR, Lashen H: Insulin-like growth factor binding protein-1 in PCOS: a systematic review and meta-analysis. Hum Reprod Update. 2011; 17:4-16. 32. Luo L, Wang Q, Chen M, Yuan G, Wang Z, Zhou C: IGF-1 and IGFBP-1 in peripheral blood and decidua of early miscarriages with euploid embryos: comparison between women with and without PCOS. Gynecol Endocrinol. 2016; 32(7):538-42. 33. Brazert M, Pawelczyk LA: Insulin-like growth factor-1 isoforms in human ovary. Preliminary report on the expression of the IGF-1 gene in PCOS patients and healthy controls. Ginekol Pol. 2015; 86(12):890-5. 34. Zheng XR, Pan X, Zhang J, Cao X: Hyperinsulinemia-induced PAX6 expression promotes endometrial epithelial cell proliferation via negatively modulating p27 signaling. Biomed Pharmacother. 2018; 97:802-8. 35. Giudice LC: Endometrium in PCOS: Implantation and predisposition to endocrine CA. Best Pract Res Clin Endocrinol Metab. 2006; 20:235-44. 36. Toth B, Jeschke U, Rogenhofer N, Scholz C, W?rfel W, Thaler CJ, Makrigiannakis A: Recurrent miscarriage: current concepts in diagnosis and treatment. J Reprod Immunol. 2010; 85(1):25-32. 37. Bastu E, Mutlu MF, Yasa C, Dural O, Nehir Aytan A, Celik C, Buyru F, Yeh J: Role of Mucin 1 and Glycodelin A in recurrent implantation failure. Fertil Steril. 2015; 103(4):1059-1064 38. Li SC, Feng M, Nie QY, Nie QY, Pan P, Wu SM, Wu JH, Cheng SX, Kang JL, Guo ZW: Predictive value of endometrial receptivity and pregnancy outcome by hysteroscopy examination at the phase of implantation window in unexplained infertile women. Zhonghua Fu Chan Ke Za Zhi. 2010; 45(3):184-90. 39. Tapia-Pizarro A, Figueroa P, Brito J, Mar?n JC, Munroe DJ, Croxatto HB: Endometrial gene expression reveals compromised progesterone signaling in women refractory to embryo implantation. Reprod Biol Endocrinol. 2014; 12:92. 40. Uysal S, Zeki Isik A, Eris S, Yigit S, Yalcin Y, Ozun Ozbay P: Correlation of endometrial glycodelin expression and pregnancy outcome in cases with polycystic ovary syndrome treated with clomiphene citrate plus metformin: a controlled study. Obstet Gynecol Int. 2015; 2015:278591. 41. Lee CL, Lam KK, Vijayan M, Koistinen H, Seppala M, Ng EH, Yeung WS, Chiu PC: The Pleiotropic Effect of Glycodelin-A in Early Pregnancy. Am J Reprod Immunol. 2016; 75(3):290-7. 42. Douglas NC, Thornton MH 2nd, Nurudeen SK, Bucur M, Lobo RA, Sauer MV: Differential expression of serum glycodelin and insulin-like growth factor binding protein 1 in early pregnancy. Reprod Sci. 2013; 20(11):1376-81. 43. Senapati S, Sammel MD, Butts SF, Takacs P, Chung K, Barnhart KT: Predicting first trimester pregnancy outcome: derivation of a multiple marker test. Fertil Steril. 2016; 106(7):1725-1732.e3.

[Amr Sharafeldeen, Hesham M. Abo Ragab and Raafat R. Mohammed. (2018); ESTIMATION OF SERUM GLYCODELIN A, INSULIN-LIKE GROWTH FACTOR-1 AND INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-3 AT 4TH WEEK GESTATIONAL AGE AS PREDICTORS FOR EARLY PREGNANCY LOSS IN PREGNANT WOMEN WITH POLYCYSTIC OVARY SYNDROME. Int. J. of Adv. Res. 6 (Feb). 1863-1872] (ISSN 2320-5407). www.journalijar.com


Amr Sharaf El-Deen
Department of Obstetrics & Gynecology, Faculty of Medicine, Benha University

DOI:


Article DOI: 10.21474/IJAR01/6629      
DOI URL: https://dx.doi.org/10.21474/IJAR01/6629